STOCK TITAN

Issuer insider sale notice — 23,767 shares (NASDAQ: TXG)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TXG files a Form 144 reporting a proposed sale of Common Stock. The notice lists 23,767 shares associated with a Restricted Stock Unit grant dated 02/21/2026. The filing also discloses an earlier sale of 11,888 shares on 11/24/2025 by Adam Taich.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice lists specific share amounts and prior sale.

The Form 144 excerpt records a proposed sale of 23,767 common shares tied to a Restricted Stock Unit grant dated 02/21/2026. It separately shows a prior disposition of 11,888 shares on 11/24/2025 by Adam Taich.

Timelines, price, and proceeds treatment are not shown in the excerpt; subsequent transaction details and broker filings will determine consummation and reporting.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does TXG's Form 144 disclose about the planned sale?

The Form 144 reports a proposed sale of 23,767 common shares tied to a Restricted Stock Unit grant dated 02/21/2026. It lists the security type as Common Stock and the sale method as a Rule 144 notice.

Who previously sold TXG shares as shown in this filing?

The excerpt shows a prior sale by Adam Taich of 11,888 common shares on 11/24/2025. That transaction is listed separately under securities sold during the past three months.

Are the sale price and proceeds disclosed in the TXG excerpt?

No sale price or net proceeds are provided in the excerpt. The record lists share counts and dates but does not include pricing or cash‑flow details for the planned or prior transactions.

What type of award generated the shares listed for sale in the TXG filing?

The shares proposed for sale—23,767—are associated with a Restricted Stock Unit (RSU) grant dated 02/21/2026 and are noted as issued for services rendered.
10X Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Latest SEC Filings

TXG Stock Data

2.41B
125.53M
Health Information Services
Laboratory Analytical Instruments
Link
United States
PLEASANTON